Viewing Study NCT00167167


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-01-12 @ 10:06 PM
Study NCT ID: NCT00167167
Status: COMPLETED
Last Update Posted: 2017-11-29
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 9510M10277
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Jeffrey Miller, MD
Old Organization: Masonic Cancer Center, University of Minnesota

Collaborators